Meyka Pro banner
iShares Russell 1000 Value ETF

Stay Updated with the Latest iShares Russell 1000 Value ETF IWD News in Real Time

Find IWD news now at Meyka AI. Stay informed with the latest iShares Russell 1000 Value ETF stocks updates, including price news, market analysis, and expert insights.

IWDAMEX
Financial ServicesAsset Management - Global
$256.62
$1.95(0.75%)
U.S. Market opens in 13h 17m
Four Pork Industry Figures Charged in $10M Cash Smuggling Scheme, August 18
📅 in about 5 hours

Four Pork Industry Figures Charged in $10M Cash Smuggling Scheme, August 18

Four pork industry figures charged with fraud and money laundering in Operation Ragamuffin. Police seized $3M cash and allege $10M in hidden sales and $30M in transported funds.

Read more 12
SK Hynix Becomes Kioxia’s De Facto Top Shareholder as Toshiba Exits
📅 2 hours ago

SK Hynix Becomes Kioxia’s De Facto Top Shareholder as Toshiba Exits

SK Hynix becomes Kioxia’s de facto top shareholder as Toshiba reduces its stake to 14.06% through seven stock sales. The Korean chipmaker holds convertible bonds that could grant it voting control.

Read more 12
Boeing (NYSE: BA) Stock Gains 8.24% in 30 Days After 737-7 Approval, but Valuation Signals 44.8% Overvaluation
📅 6 hours ago

Boeing (NYSE: BA) Stock Gains 8.24% in 30 Days After 737-7 Approval, but Valuation Signals 44.8% Overvaluation

Boeing (NYSE: BA) stock has gained 8.24% over the past 30 days as investors respond to improving conditions in the company’s commercial aircraft business. A major catalyst came on August 3, 2026, when the U.S. Federal Aviation Administration certified Boeing’s long-delayed 737-7 for commercial service. The approval supports Boeing’s recovery story, but a reported 44.8%…

Read more 12
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
📅 7 hours ago

AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit

AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review.  This marks AstraZeneca’s second major trial halt…

Read more 12
Hindustan Copper (NSE: HINDCOPPER) Shares Surge 7.36% to ₹568 as Global Copper Prices Rebound
📅 7 hours ago

Hindustan Copper (NSE: HINDCOPPER) Shares Surge 7.36% to ₹568 as Global Copper Prices Rebound

Hindustan Copper shares surged 7.36% to ₹568 on Monday, August 17, 2026, tracking a global copper rally. The stock climbed from Friday’s close of ₹528.85, touching an intraday high of ₹574.90. COMEX copper futures rose 1.72% to $6.72 per pound, while LME spot prices pushed toward record levels.  Supply tightness across major exchanges is now…

Read more 12
Ukraine’s $48,000 MICH 2000 Drone Destroyed Russian Tu-95 Bomber on August 16
📅 8 hours ago

Ukraine’s $48,000 MICH 2000 Drone Destroyed Russian Tu-95 Bomber on August 16

Ukraine’s MICH 2000 drone, reverse-engineered from Chinese aircraft and costing $48,000, destroyed a Russian Tu-95 bomber. The 2,000 km range drone was built after Ukrainian teams photographed a Chinese factory in 2023.

Read more 12
Lee Kuan Yew’s Montblanc Pen Sells for S$461,500 at Singapore Auction, August 17
📅 8 hours ago

Lee Kuan Yew’s Montblanc Pen Sells for S$461,500 at Singapore Auction, August 17

Lee Kuan Yew’s engraved Montblanc fountain pen sold for S$461,500 at Hotlotz auction on August 16, nearly 10 times its S$30,000-S$50,000 estimate, after 111 bids from around the world.

Read more 12
Dhoot Transmission (NSE: DHOT) Shares Jump 38% on India Debut, Valuation Hits $2.5 Billion
📅 9 hours ago

Dhoot Transmission (NSE: DHOT) Shares Jump 38% on India Debut, Valuation Hits $2.5 Billion

Dhoot Transmission shares made a strong stock market debut on August 17, 2026, rising nearly 38% above the IPO issue price. The auto components maker listed at ₹1,200 on the NSE, compared with its ₹871 issue price. The ₹3,067-crore IPO also drew heavy demand, with subscriptions reaching 74.21 times. The sharp debut lifted the company’s…

Read more 12
Alibaba (NYSE: BABA) to Sell Lingxi Games to Trustar Capital in Deal Worth Over $2 Billion
📅 9 hours ago

Alibaba (NYSE: BABA) to Sell Lingxi Games to Trustar Capital in Deal Worth Over $2 Billion

Alibaba Group Holding Limited agreed on August 17, 2026, to sell its gaming arm, Lingxi Games, to Trustar Capital. The deal values the gaming unit at above $2 billion. Alibaba shares rose 1.25% to trade near $84.50 following the announcement. This transaction aligns with the tech giant’s strategy to shed non-core assets and focus on…

Read more 12

IWD News FAQ